Pioneering Portable Neurostimulation

Millions of patients and physicians aim to manage neurological symptoms of disease or trauma, with limited ways to rehabilitate lost function. Helius is studying the PoNS™ device as a new potential treatment option.

Discover HMT

The Revolution in Mind

With a sharp focus on unique, noninvasive platform technologies, Helius Medical Technologies (Helius) is the medical device holding company working to expand treatment options for patients by amplifying the brain’s ability to heal itself.

DISCOVER HMT

Advancing Neurological Treatment Technologies

Through collaboration with distinguished research and production partners, Helius is developing and testing breakthrough technologies as potential treatments for neurological symptoms caused by disease or trauma.

SEE OUR CLINICAL TRIALS

Pioneering Portable Neurostimulation

Millions of patients and physicians aim to manage neurological symptoms of disease or trauma, with limited ways to rehabilitate lost function. Helius is studying the PoNS™ device as a new potential treatment option.

EXPLORE THE PONS DEVICE

Helius News

Info For Investors

Helius Medical Technologies is a publicly traded company on the Toronto Stock Exchange under symbol HSM and on the NASDAQ marketplace under symbol HSDT.

More Info